This product is a long-acting non-steroidal anti-inflammatory drug. It can inhibit the activity of cyclooxygenase and reduce the synthesis of prostaglandins. Animal experiments show that the anti-inflammatory and analgesic effects of this product are weaker than indomethacin, but stronger than aspirin.

A mild peripheral vasodilator with the pharmacological effects of niacin and inositol, and lipid-lowering effects; the vasodilator effect is milder and more lasting than that of niacin, without the side effects of flushing and stomach discomfort; it selectively dilates blood vessels in diseased areas and sensitive areas stimulated by cold; it has the effects of dissolving blood clots, anti-coagulation, anti-fatty liver, and reducing capillary fragility.

It has astringent, gastric mucosal protective and antibacterial effects. After oral administration, a protective film is formed on the gastric mucosal wound surface, reducing the irritation of food to the gastric mucosa; in the intestine, bismuth combines with hydrogen sulfide to form insoluble bismuth sulfide (Bi2S3) on the intestinal mucosa, slowing down intestinal peristalsis; at the same time, bismuth salts also have antibacterial effects.

This product is an antacid. After oral administration, it can quickly neutralize gastric acid. The generated bismuth salt can form a protective film on the surface of the ulcer at the inflammation site, resisting the invasion of gastric acid and having a convergence effect. In addition, it can also kill Helicobacter pylori and promote the healing of inflammation.

Extract from the above information